Cryptosporidiosis

27 registered clinical trials studyying Cryptosporidiosis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Nitazoxanide for Treatment of Cryptosporidium in Children NCT06600711	Johns Hopkins Bloomberg School of Public Health	Phase 3
Recruiting	Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy A NCT07249463	Novartis Pharmaceuticals	Phase 2
Active Not Recruiting	Cryptosporidiosis and Enteropathogens in Bangladesh NCT02764918	University of Virginia	—
Recruiting	Cryptosporidium Species in Sohag Governorate NCT05208970	Sohag University	—
Unknown	Cryptosporidium Infection and Human Colorectal Cancer NCT04332705	Lille Catholic University	—
Completed	Treatment of Cryptosporidiosis NCT04103216	International Centre for Diarrhoeal Disease Research, Bangladesh	N/A
Terminated	A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosp NCT03341767	University of Washington	Phase 2
Completed	Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya NCT01695304	Centers for Disease Control and Prevention	N/A
Completed	Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events NCT01699841	Cornell University	—
Completed	Transmission and the Respiratory Tract in Cryptosporidiosis NCT00507871	Tufts University	—
Terminated	Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients NCT00004986	Romark Laboratories L.C.	Phase 3
Terminated	Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients NCT00057486	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1 / Phase 2
Terminated	Parasitic Infections of the Gastrointestinal Tract NCT00001162	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children NCT00055107	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1 / Phase 2
Completed	A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety o NCT00002248	Univax Biologics Inc	Phase 1
Terminated	Treatment of Chronic Cryptosporidiosis in AIDS Patients NCT00001128	National Institute of Allergy and Infectious Diseases (NIAID)	N/A
Completed	Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidio NCT00002062	Rhone-Poulenc Rorer	N/A
Completed	A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS NCT00002278	Janssen, LP	N/A
Completed	A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea NCT00000980	Rhone-Poulenc Rorer	Phase 1
Completed	A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium NCT00001081	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS) NCT00002082	Pfizer	N/A
Unknown	A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis NCT00002158	Romark Laboratories L.C.	N/A
Completed	The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea NCT00002264	Stolle Milk Biologic International	N/A
Completed	Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs NCT00002328	Pfizer	N/A
Completed	A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea NCT00001018	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Ad NCT00000771	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) NCT00002027	Janssen, LP	N/A